A new study by Brown University researchers suggests that gold nanoparticles—microscopic bits of gold thousands of times ...

A new study by Brown University researchers suggests that gold nanoparticles - microscopic bits of gold thousands of times ...

Regeneron aims for FDA approval of extended dosing for EYLEA HD in AMD and DME, with a decision by April 2025. Pre-filled ...

Not since the fall of Singapore has there been such apprehension about the future of Australia. Given the precarious state of ...

CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making ...

We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look ...

Yesafili, a vascular endothelial growth factor inhibitor, is used to treat several different types of ophthalmology ...

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...